title: Safety of rituximab therapy during twins' pregnancy.
authors.forename: Evelien
authors.initials: E
authors.lastname: Ton
authors.forename: Janneke
authors.initials: J
authors.lastname: Tekstra
authors.forename: Petra M
authors.initials: PM
authors.lastname: Hellmann
authors.forename: Ike H H
authors.initials: IH
authors.lastname: Nuver-Zwart
authors.forename: Johannes W J
authors.initials: JW
authors.lastname: Bijlsma
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000166:cytology; D003025:Clubfoot / Q000453:epidemiology; D004890:Erythema / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn / Q000097:blood; D018655:Lymphocyte Count; D011247:Pregnancy / Q000502:physiology*; D011256:Pregnancy Outcome; D012213:Rheumatic Fever / Q000188:drug therapy*; D000069283:Rituximab; D014427:Twins
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab